Clinical Trial Update: Efalizumab for Eczema [Phase 2]

View source ↗

Summary

Phase 2 trial of efalizumab for atopic dermatitis has completed, with results disseminated in an update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED